What is ResMed's total cost of revenue?

ResMed (RMD) reported total cost of revenue of $540.43M in Q1 2026.

How has ResMed's total cost of revenue changed year-over-year?

ResMed's total cost of revenue increased by 2.9% year-over-year, from $525.33M to $540.43M.

What is the long-term trend for ResMed's total cost of revenue?

Over 3 years (2022 to 2025), ResMed's total cost of revenue has grown at a 10.4% compound annual growth rate (CAGR), from $1.55B to $2.09B.

What does total cost of revenue mean?

The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

ResMed RMD Total Cost of Revenue

Discontinued — last reported Q3 '26

Total Cost of Revenue at other companies

Eli LillyLLY

$3.58B+60.8%

Inspire Medical SystemsINSP

$27.67M-9.9%

Viemed Healthcare, Inc.VMD

$32.59M+26.1%

LivaNovaLIVN

$118.51M+17.8%

AdaptHealthAHCO

$708.3M+7.7%

MedtronicMDT

$3.4B+8.0%

Segments

By segment

See full

Sleep And Breathing Health$479.19M+2.6%

Residential Care Software$50.86M+5.2%

By product

See full

Sleep And Breathing Health$481.72M+2.6%

Residential Care Software$50.86M+5.2%

Other financials

Income statement

See full

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$29.05B-22.6%

Enterprise value$28.5B-23.3%

P/E19.1×-7.7×

P/S5.3×-2.0×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's total cost of revenue?: ResMed (RMD) reported total cost of revenue of $540.43M in Q1 2026.
How has ResMed's total cost of revenue changed year-over-year?: ResMed's total cost of revenue increased by 2.9% year-over-year, from $525.33M to $540.43M.
What is the long-term trend for ResMed's total cost of revenue?: Over 3 years (2022 to 2025), ResMed's total cost of revenue has grown at a 10.4% compound annual growth rate (CAGR), from $1.55B to $2.09B.
What does total cost of revenue mean?: The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.